|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Using quality of life to predict hos- pitalization and mortality in patients with obstructive lung diseases 显示文摘 | Fan VS Curtis JR Tu SP | 2002 | Chest2002，122，42： | 1 |
| 2 | Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases 显示文摘 | Fan VS Curtis JR Tu SP | 2002 | Chest2002，122，2： | 1 |
| 3 | Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term(MEDAL)programme:a randomised comparison显示文摘 | Laine L Curtis SP Cryer B | 2007 | Lancet2007，369，9560： | 1 |
| 4 | A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis显示文摘 | Collantes E Curtis SP Lee KW | 2002 | BMC Fam Pract2002，22，3： | 1 |
| 5 | Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti- inflammatory drug diclofenac显示文摘 | Laine L Curtis SP Langman M | 2008 | Gastroenterology2008，135，5： | 1 |
| 6 | The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups 显示文摘 | Curtis C Shah SP Chin SF | 2012 | Nature2012，486，7403： | 1 |
| 7 | Renal effects of etoricoxib and comparator nonsteroidal antiinflammatory drugs in controlled clinical trails显示文摘 | CURTIS SP NG J YU Q | 2004 | Clin Ther2004，26，1： | 1 |
| 8 | Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases显示文摘 | Fan VS Curtis JR Tu SP | 2002 | Chest2002，122，2： | 1 |
| 9 | The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups显示文摘 | Curtis C Shah SP Chin SF | 2012 | Nature2012，486，7403： | 1 |
| 10 | The genomic and transcrip- tomic architecture of 2, 000 breast turnouts reveals novel subgroups 显示文摘 | Curtis C Shah SP Chin SF | 2012 | Nature2012，486，7403： | 1 |
| 11 | A multinational randomized,controlled,clinical trial of etoricoxib in the treatment of rheumatoid arthritis显示文摘 | Collantes E Curtis SP Lee KW | 2002 | BMC Fam Pract2002，3，1： | 1 |
| 12 | Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases 显示文摘 | Fan VS Curtis JR Tu SP | 2002 | Chest2002，122，2： | 1 |
| 13 | How common is diclofenac- associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial 显示文摘 | Laine L Goldkind L Curtis SP et at | 2009 | Am J Gastroenterol2009，104，： | 1 |
| 14 | The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups 显示文摘 | Curtis C Shah SP Chin SF | 2012 | Nature2012，486，7403： | 1 |
| 15 | Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the multinational etoricoxib and diclofenac arthritis long-term (MEDAL) programme: a randomised comparison 显示文摘 | Cannon CP Curtis SP FitzGerald GA | 2006 | Lancet2006，368，： | 1 |
| 16 | The genomic and tran-scriptomic architecture of 2,000 breast tumours reveals no- vel subgroups 显示文摘 | Curtis C Shah SP Chin SF | 2012 | Nature2012，486，7403： | 1 |
| 17 | Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases 显示文摘 | Fan VS Curtis JR Tu SP | 2002 | Chest2002，122，2： | 1 |
| 18 | Actors associated with bloodpressure changes in patients receiving diclofenac of etoricoxib:results from the MEDAL study显示文摘 | Krum H’Swergold G Curtis SP | 2009 | J Hypertens2009，27，4： | 1 |
| 19 | Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases显示文摘 | Fan VS Curtis JR Tu SP | | 0，，02： | 1 |
| 20 | The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups显示文摘 | Curtis C Shah SP Chin SF | 2012 | Nature2012，486，7403： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员